Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

Acute graft-versus-host disease (aGVHD) is the primary limitation of allogeneic hematopoietic cell transplantation. Corticosteroids remain the standard initial therapy, yet only 25% to 41% of patients completely respond. This randomized, 4-arm, phase 2 trial was designed to identify the most promisi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Alousi, Amin M., Weisdorf, Daniel J., Logan, Brent R., Bolaños-Meade, Javier, Carter, Shelly, DiFronzo, Nancy, Pasquini, Marcelo, Goldstein, Steven C., Ho, Vincent T., Hayes-Lattin, Brandon, Wingard, John R., Horowitz, Mary M., Levine, John E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2009
Ämnen:
Clinical Trials and Observations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713466/
https://ncbi.nlm.nih.gov/pubmed/19443659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-212290
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk